INSERM UMR-S 1270; Institut du Fer à Moulin, Sorbonne Université, F-75005, Paris, France.
Institut des Neurosciences Paris-Saclay, UMR 9197, CNRS, Université Paris-Saclay, Saclay, France.
Mol Psychiatry. 2024 Aug;29(8):2296-2307. doi: 10.1038/s41380-024-02483-y. Epub 2024 Mar 7.
Mutations of PAK3, a p21-activated kinase, are associated in humans with cognitive deficits suggestive of defective cortical circuits and with frequent brain structural abnormalities. Most human variants no longer exhibit kinase activity. Since GABAergic interneurons express PAK3 as they migrate within the cortex, we here examined the role of PAK3 kinase activity in the regulation of cortical interneuron migration. During the embryonic development, cortical interneurons migrate a long distance tangentially and then re-orient radially to settle in the cortical plate, where they contribute to cortical circuits. We showed that interneurons expressing a constitutively kinase active PAK3 variant (PAK3-ca) extended shorter leading processes and exhibited unstable polarity. In the upper cortical layers, they entered the cortical plate and extended radially oriented processes. In the deep cortical layers, they exhibited erratic non-processive migration movements and accumulated in the deep pathway. Pharmacological inhibition of PAK3 kinase inhibited the radial migration switch of interneurons to the cortical plate and reduced their accumulation in the deep cortical layers. Interneurons expressing a kinase dead PAK3 variant (PAK3-kd) developed branched leading processes, maintained the same polarity during migration and exhibited processive and tangentially oriented movements in the cortex. These results reveal that PAK3 kinase activity, by promoting leading process shortening and cell polarity changes, inhibits the tangential processive migration of interneurons and favors their radial re- orientation and targeting to the cortical plate. They suggest that patients expressing PAK3 variants with impaired kinase activity likely present alterations in the cortical targeting of their GABAergic interneurons.
PAK3(一种 p21 激活激酶)的突变与人类认知缺陷有关,这些缺陷表明皮质回路存在缺陷,且大脑结构异常频繁。大多数人类变异体不再表现出激酶活性。由于 GABA 能中间神经元在皮质内迁移时表达 PAK3,我们在此研究了 PAK3 激酶活性在调节皮质中间神经元迁移中的作用。在胚胎发育过程中,皮质中间神经元进行长距离切线迁移,然后重新定向为放射状迁移,以定居在皮质板中,从而为皮质回路做出贡献。我们发现,表达组成型激酶活性 PAK3 变体(PAK3-ca)的中间神经元延伸的前导突起较短,表现出不稳定的极性。在上层皮质中,它们进入皮质板并延伸出放射状的突起。在深层皮质中,它们表现出不稳定的非程序性迁移运动,并在深层通路上积累。PAK3 激酶的药理学抑制抑制了中间神经元向皮质板的放射状迁移转换,并减少了它们在深层皮质中的积累。表达激酶失活 PAK3 变体(PAK3-kd)的中间神经元发育出分支的前导突起,在迁移过程中保持相同的极性,并在皮质中表现出具有程序性和切线方向的运动。这些结果表明,PAK3 激酶活性通过促进前导突起缩短和细胞极性变化,抑制中间神经元的切线程序性迁移,并有利于它们的放射状重新定向和向皮质板的靶向。它们表明,表达激酶活性受损的 PAK3 变体的患者可能会出现其 GABA 能中间神经元皮质靶向的改变。
Cereb Cortex. 2019-4-1
Neuron. 2007-6-21
Cereb Cortex. 2010-8-16
Cold Spring Harb Mol Case Stud. 2019-12-13
Am J Hum Genet. 2018-10-4
Cereb Cortex. 2019-4-1